[1858] EGFR Mutation and p53 Overexpression in the AAH-BAC-Small Adenocarcinoma Sequence of the Lung
SB Yoo, HJ Lee, CT Lee, SH Jheon, JH Chung. Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
Background: A progression model of atypical adenomatous hyperplasia (AAH) to bronchioloalveolar carcinoma (BAC) to invasive adenocarcinoma(ADC) has been proposed. However, the genetic alterations of the AAH-BAC-ADC sequence are not clearly established. We examined the mutation of the epidermal growth factor receptor (EGFR) gene and p53 protein overexpression in the AAH, BAC and small ADC to understand their role in the pulmonary adenocarcinoma pathogenesis.
Design: Twenty AAH, 39 BAC (19 Noguchi type A and 20 type B) and 32 ADC (Noguchi type C) were enrolled in this study. EGFR mutations at exons 18-21 and p53 protein expression were examined by PCR-direct sequencing and immunohistochemistry, respectively.
Results: Mutations of the EGFR gene were noted in 32 (35.2%) lesions, which included 7 (35.0%) of AAH, 13 (33.3%) of BAC and 12 (37.5%) of small ADC. Eighteen (19.8%) of the mutations were detected as exon 19 deletion, 13 (14.3%) as exon 21 point mutation and 1 (1.1%) as exon 18 point mutation. Overexpression of p53 protein was found in 16 (17.6%) lesions, none of AAH, 4 (10.3%) of BAC and 12 (37.5%) of ADC.
| Histology (no.) | EGFR gene mutation negative | EGFR gene mutation positive | p value | p53 protein expression negative | p53 protein expression positive | p value |
| AAH (20) | 13 (65.0%) | 7 (35.0%) | 20 (100.0%) | 0 (0.0%) | ||
| BAC (39) | 26 (66.7%) | 13 (33.3%) | 35 (89.7%) | 4 (10.3%) | ||
| ADC (32) | 20 (62.5%) | 12 (37.5%) | 20 (62.5%) | 12 (37.5%) | ||
| Total (91) | 59 (64.8%) | 32 (35.2%) | 0.935 | 75 (82.4%) | 16 (17.6%) | 0.001 |